Utah Medical Products (UTMD) Accounts Payables (2010 - 2026)

Utah Medical Products' Accounts Payables history runs 17 years deep, the most recent figure standing at $1.2 million for Q1 2026.

• On a quarterly basis, Accounts Payables rose 30.63% year-over-year to $1.2 million in Q1 2026; TTM through Mar 2026 was $1.2 million, a 30.63% increase from a year earlier, with the FY2025 full-year figure at $911000.0, up 30.89% from the prior year.
• Accounts Payables advanced to $1.2 million in Q1 2026 per UTMD's latest filing, from $911000.0 in the prior quarter.
• Across five years, Accounts Payables topped out at $1.5 million in Q1 2022 and bottomed at $511000.0 in Q3 2023.
• The 5-year median for Accounts Payables is $914000.0 (2025), against an average of $969058.8.
• Across the five-year window, Accounts Payables tumbled 60.36% in 2023 and soared 95.5% in 2024, its largest moves.
• Year by year, Accounts Payables stood at $1.2 million in 2022, then plunged by 36.86% to $769000.0 in 2023, then fell by 9.49% to $696000.0 in 2024, then jumped by 30.89% to $911000.0 in 2025, then soared by 31.06% to $1.2 million in 2026.
• Per Business Quant, the three latest UTMD Accounts Payables figures stand at $1.2 million (Q1 2026), $911000.0 (Q4 2025), and $768000.0 (Q3 2025).